LMNL Annual SG&A
$13.73 M
-$11.73 M-46.08%
31 December 2022
Summary:
As of January 23, 2025, LMNL annual selling, general & administrative expenses is $13.73 million, with the most recent change of -$11.73 million (-46.08%) on December 31, 2022. During the last 3 years, it has fallen by -$14.64 million (-51.61%).LMNL Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL Quarterly SG&A
$3.55 M
+$920.10 K+34.98%
30 June 2023
Summary:
As of January 23, 2025, LMNL quarterly selling, general & administrative expenses is $3.55 million, with the most recent change of +$920.10 thousand (+34.98%) on June 30, 2023. Over the past year, it has dropped by -$86.10 thousand (-2.37%).LMNL Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL TTM SG&A
-$3.22 B
+$17.26 M+0.53%
30 June 2023
Summary:
As of January 23, 2025, LMNL TTM selling, general & administrative expenses is -$3.22 billion, with the most recent change of +$17.26 million (+0.53%) on June 30, 2023. Over the past year, it has dropped by -$3.24 billion (-16665.59%).LMNL TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.1% | -2.4% | -10000.0% |
| 3 y3 years | -51.6% | -42.1% | -10000.0% |
| 5 y5 years | -39.8% | -34.0% | -10000.0% |
LMNL Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -51.6% | -73.7% | -9927.0% |
Liminal BioSciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $3.55 M(+35.0%) | $12.44 M(-0.7%) |
| Mar 2023 | - | $2.63 M(-9.3%) | $12.53 M(-7.9%) |
| Dec 2022 | $13.73 M(-46.1%) | $2.90 M(-13.7%) | $13.60 M(-11.2%) |
| Sept 2022 | - | $3.36 M(-7.6%) | $15.32 M(-21.2%) |
| June 2022 | - | $3.64 M(-1.9%) | $19.44 M(-14.6%) |
| Mar 2022 | - | $3.71 M(-19.7%) | $22.77 M(-10.6%) |
| Dec 2021 | $25.47 M(+4.6%) | $4.62 M(-38.3%) | $25.48 M(-4.3%) |
| Sept 2021 | - | $7.48 M(+7.4%) | $26.62 M(+7.4%) |
| June 2021 | - | $6.96 M(+8.5%) | $24.79 M(+3.5%) |
| Mar 2021 | - | $6.42 M(+11.5%) | $23.97 M(-6.0%) |
| Dec 2020 | $24.35 M(-14.2%) | $5.76 M(+1.9%) | $25.49 M(+17.2%) |
| Sept 2020 | - | $5.65 M(-7.8%) | $21.74 M(-7.7%) |
| June 2020 | - | $6.13 M(-22.8%) | $23.56 M(-23.8%) |
| Mar 2020 | - | $7.94 M(+294.9%) | $30.91 M(+9.2%) |
| Dec 2019 | $28.38 M(+24.9%) | $2.01 M(-73.1%) | $28.30 M(-13.7%) |
| Sept 2019 | - | $7.47 M(-44.6%) | $32.77 M(+9.0%) |
| June 2019 | - | $13.48 M(+152.8%) | $30.07 M(+36.9%) |
| Mar 2019 | - | $5.33 M(-17.8%) | $21.96 M(-3.4%) |
| Dec 2018 | $22.72 M(-0.4%) | $6.49 M(+36.3%) | $22.73 M(+4.9%) |
| Sept 2018 | - | $4.76 M(-11.6%) | $21.67 M(-5.8%) |
| June 2018 | - | $5.38 M(-11.8%) | $23.01 M(-2.6%) |
| Mar 2018 | - | $6.10 M(+12.4%) | $23.62 M(+3.7%) |
| Dec 2017 | $22.81 M(+6.1%) | $5.43 M(-11.1%) | $22.77 M(-13.5%) |
| Sept 2017 | - | $6.11 M(+1.9%) | $26.32 M(+4.5%) |
| June 2017 | - | $5.99 M(+14.2%) | $25.18 M(+8.5%) |
| Mar 2017 | - | $5.25 M(-41.6%) | $23.21 M(+8.0%) |
| Dec 2016 | $21.50 M(+65.6%) | $8.98 M(+80.9%) | $21.48 M(+30.3%) |
| Sept 2016 | - | $4.96 M(+23.4%) | $16.49 M(+12.3%) |
| June 2016 | - | $4.02 M(+14.4%) | $14.69 M(+7.0%) |
| Mar 2016 | - | $3.52 M(-11.9%) | $13.73 M(+6.3%) |
| Dec 2015 | $12.99 M(+18.0%) | $3.99 M(+26.5%) | $12.91 M(+4.9%) |
| Sept 2015 | - | $3.16 M(+3.0%) | $12.31 M(+1.9%) |
| June 2015 | - | $3.07 M(+13.4%) | $12.08 M(+5.2%) |
| Mar 2015 | - | $2.70 M(-20.1%) | $11.48 M(+7.2%) |
| Dec 2014 | $11.00 M(+36.0%) | $3.38 M(+15.5%) | $10.71 M(-1.8%) |
| Sept 2014 | - | $2.93 M(+18.7%) | $10.91 M(+10.3%) |
| June 2014 | - | $2.47 M(+27.9%) | $9.89 M(+13.8%) |
| Mar 2014 | - | $1.93 M(-46.2%) | $8.69 M(+5.4%) |
| Dec 2013 | $8.09 M(+38.8%) | $3.58 M(+87.9%) | $8.25 M(+24.9%) |
| Sept 2013 | - | $1.91 M(+50.1%) | $6.60 M(+11.1%) |
| June 2013 | - | $1.27 M(-14.5%) | $5.94 M(+0.3%) |
| Mar 2013 | - | $1.49 M(-23.4%) | $5.93 M(+1.6%) |
| Dec 2012 | $5.83 M | $1.94 M(+55.1%) | $5.84 M(+10.9%) |
| Sept 2012 | - | $1.25 M(-0.3%) | $5.26 M(-3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | $1.25 M(-10.1%) | $5.47 M(-3.3%) |
| Mar 2012 | - | $1.39 M(+2.1%) | $5.65 M(-3.4%) |
| Dec 2011 | $5.85 M(+9.7%) | $1.37 M(-6.0%) | $5.86 M(+0.8%) |
| Sept 2011 | - | $1.45 M(+0.9%) | $5.81 M(+3.1%) |
| June 2011 | - | $1.44 M(-9.8%) | $5.64 M(+2.9%) |
| Mar 2011 | - | $1.60 M(+20.8%) | $5.48 M(+2.6%) |
| Dec 2010 | $5.34 M(+31.9%) | $1.32 M(+3.3%) | $5.34 M(+5.9%) |
| Sept 2010 | - | $1.28 M(-0.4%) | $5.04 M(+7.4%) |
| June 2010 | - | $1.28 M(-11.8%) | $4.69 M(+5.9%) |
| Mar 2010 | - | $1.46 M(+42.1%) | $4.43 M(+10.1%) |
| Dec 2009 | $4.05 M(-19.3%) | $1.02 M(+10.2%) | $4.03 M(-2.9%) |
| Sept 2009 | - | $929.70 K(-9.1%) | $4.15 M(-2.8%) |
| June 2009 | - | $1.02 M(-2.3%) | $4.26 M(-12.1%) |
| Mar 2009 | - | $1.05 M(-8.5%) | $4.85 M(-6.4%) |
| Dec 2008 | $5.02 M(-18.8%) | $1.14 M(+9.3%) | $5.18 M(-18.8%) |
| Sept 2008 | - | $1.05 M(-34.9%) | $6.38 M(-4.6%) |
| June 2008 | - | $1.61 M(+16.7%) | $6.69 M(+4.5%) |
| Mar 2008 | - | $1.38 M(-41.1%) | $6.40 M(+2.1%) |
| Dec 2007 | $6.18 M(-12.4%) | $2.34 M(+72.9%) | $6.26 M(+3.5%) |
| Sept 2007 | - | $1.35 M(+2.6%) | $6.05 M(-10.6%) |
| June 2007 | - | $1.32 M(+6.0%) | $6.76 M(-3.7%) |
| Mar 2007 | - | $1.25 M(-41.5%) | $7.02 M(-0.6%) |
| Dec 2006 | $7.05 M(+26.7%) | $2.13 M(+2.8%) | $7.06 M(+9.8%) |
| Sept 2006 | - | $2.07 M(+30.8%) | $6.43 M(+14.2%) |
| June 2006 | - | $1.58 M(+23.1%) | $5.63 M(+1.2%) |
| Mar 2006 | - | $1.28 M(-14.0%) | $5.56 M(-0.0%) |
| Dec 2005 | $5.57 M(+37.1%) | $1.49 M(+17.8%) | $5.57 M(+12.6%) |
| Sept 2005 | - | $1.27 M(-16.2%) | $4.94 M(+3.1%) |
| June 2005 | - | $1.52 M(+17.8%) | $4.79 M(+10.2%) |
| Mar 2005 | - | $1.29 M(+47.6%) | $4.35 M(+5.8%) |
| Dec 2004 | $4.06 M(+0.4%) | $871.50 K(-22.1%) | $4.11 M(-3.1%) |
| Sept 2004 | - | $1.12 M(+4.3%) | $4.24 M(+4.9%) |
| June 2004 | - | $1.07 M(+2.4%) | $4.04 M(+36.1%) |
| Mar 2004 | - | $1.05 M(+4.7%) | $2.97 M(+5.9%) |
| Dec 2003 | $4.05 M(+11.2%) | $1.00 M(+8.6%) | $2.81 M(+55.5%) |
| Sept 2003 | - | $922.00 K(+4.6%) | $1.80 M(+104.6%) |
| Mar 2003 | - | $881.80 K(+19.2%) | $881.80 K(+19.2%) |
| Dec 2002 | $3.64 M(+50.9%) | - | - |
| Sept 1999 | - | $739.90 K(+40.0%) | $739.90 K(-79.1%) |
| Sept 1998 | - | $528.60 K(-55.0%) | $3.53 M(+17.6%) |
| June 1998 | - | $1.18 M(+12.0%) | $3.01 M(+64.2%) |
| Mar 1998 | - | $1.05 M(+34.4%) | $1.83 M(+134.4%) |
| Dec 1997 | - | $781.00 K | $781.00 K |
| Sept 1997 | $2.41 M | - | - |
FAQ
- What is Liminal BioSciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Liminal BioSciences?
- What is Liminal BioSciences annual SG&A year-on-year change?
- What is Liminal BioSciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Liminal BioSciences?
- What is Liminal BioSciences quarterly SG&A year-on-year change?
- What is Liminal BioSciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Liminal BioSciences?
- What is Liminal BioSciences TTM SG&A year-on-year change?
What is Liminal BioSciences annual selling, general & administrative expenses?
The current annual SG&A of LMNL is $13.73 M
What is the all time high annual SG&A for Liminal BioSciences?
Liminal BioSciences all-time high annual selling, general & administrative expenses is $28.38 M
What is Liminal BioSciences annual SG&A year-on-year change?
Over the past year, LMNL annual selling, general & administrative expenses has changed by -$11.73 M (-46.08%)
What is Liminal BioSciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of LMNL is $3.55 M
What is the all time high quarterly SG&A for Liminal BioSciences?
Liminal BioSciences all-time high quarterly selling, general & administrative expenses is $13.48 M
What is Liminal BioSciences quarterly SG&A year-on-year change?
Over the past year, LMNL quarterly selling, general & administrative expenses has changed by -$86.10 K (-2.37%)
What is Liminal BioSciences TTM selling, general & administrative expenses?
The current TTM SG&A of LMNL is -$3.22 B
What is the all time high TTM SG&A for Liminal BioSciences?
Liminal BioSciences all-time high TTM selling, general & administrative expenses is $32.77 M
What is Liminal BioSciences TTM SG&A year-on-year change?
Over the past year, LMNL TTM selling, general & administrative expenses has changed by -$3.24 B (-16665.59%)